Navigation Links
Allied Minds Launches Novel Disinfectant/Disinfestant Technology Start-up With UC Davis
Date:6/30/2008

Investment Firm, Allied Minds, Establishes New Company to Commercialize

Novel Technology from UC Davis

BOSTON, June 30 /PRNewswire/ -- Allied Minds, a pre-seed investment firm specializing in early stage university business ventures, has established RF Biocidics, Inc., to develop and commercialize a novel disinfectant and disinfestant technology invented at UC Davis.

The newly formed RF Biocidics, Inc. is developing a novel "cleantech" approach using radio frequency (RF) heating to eliminate pathogens and insects without the use of dangerous chemicals or radiation. Traditional efforts to disinfect and disinfest food and agricultural products, have primarily utilized chemical, heat, or radiation inputs with often undesirable results. These methods have inherent problems: 1) toxins are introduced into the food chain and the environment; 2) permanent changes occur in the sensory and nutritional quality of most produce; and 3) radiation drives high the cost of handling and holds a negative consumer perception.

RF heating resolves these issues by delivering lethal energy to insects and microbes without disturbing or damaging the host material or leaving behind any molecules. In general, RF heating eliminates surface heating, reducing thermal loads and allowing a food's quality and nutritional attributes to be maintained. RFB technology is being developed by Professor Manuel Lagunas-Solar of UC Davis.

"We look forward to exploring the many potential applications this technology will encompass. We see benefits in food safety, agriculture, medical sterilization, and as an anti-bioterrorism measure, among others," said Allied Minds COO Marc Eichenberger.

The initial funding for RF Biocidics is being provided by Allied Minds. To learn more about RF Biocidics, please visit http://www.rfbiocidics.com .

About Allied Minds, Inc.

Allied Minds is a seed investment company creating partnerships with key universities to fund corporate spinouts resulting from successful early stage technology research. By providing corporate development support as well as finance, Allied Minds aims to guide early stage companies to commercial success, thereby generating value for all stakeholders. For addition information, logon to http://www.alliedminds.com .


'/>"/>
SOURCE Allied Minds, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Four Independent Research Groups Present Data Generated by Pressure Cycling Technology (PCT) at the ASMS Conference on Mass Spectrometry and Allied Topics in Denver, CO
2. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
3. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
4. Glycominds Appoints Board of Directors Chairman
5. Glycominds and Fox Chase Cancer Center Announce a Collaboration to Discover New Cancer Detection Diagnostic Tests
6. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
7. Novozymes Launches Enzyme to Reduce Acrylamide in Food
8. Enova Medical Launches Exos Corporation
9. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
10. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
11. ThirdBiotech Networking Group Launches
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
Breaking Biology Technology:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
Breaking Biology News(10 mins):